CanPrev Liposomal NAC - N-Acetyl-Cysteine Antioxidant Liquid | 225mL
Visit the CanPrev Store| Brand | CanPrev |
| Serving | 1 teaspoon (5ml) |
| Licensed Natural Health Product | NPN 80109358 |
| Quality Standards | GMP-compliant facility |
| Country | Made in USA  |
About this item
- PROVIDES ANTIOXIDANTS: A liposomal liquid delivering 60mg of N-Acetyl-Cysteine (NAC) per teaspoon - the Health Canada-authorized use of this product is that it provides antioxidants.
- A KEY BUILDING BLOCK FOR GLUTATHIONE: NAC is a stable, stomach-friendly form of the amino acid cysteine, and cysteine is the rate-limiting building block the body uses to make glutathione, its main intracellular antioxidant.
- FAST-ACTING LIPOSOMAL FORMULA: CanPrev's liposomal technology wraps NAC in bio-friendly, soy-free phospholipids sourced from sunflower, designed for rapid and sustained cellular uptake compared with a standard capsule.
- PLEASANT STRAWBERRY LIQUID, NO CAPSULES: A natural strawberry, raspberry and vanilla-flavoured liquid taken by the teaspoon - no capsules to swallow, with no artificial colours, flavours or preservatives.
- SIMPLE ONE-TEASPOON DAILY DOSE: Just one teaspoon (5ml) per day with food, or as directed by a health care practitioner - 45 servings per 225ml bottle.
- VEGAN, MADE WITHOUT FILLERS: Vegan, non-GMO, gluten-free, dairy-free and soy-free, with no artificial colours, flavours or preservatives - just NAC and the liposomal carrier.
Product Description
Liposomal NAC - Fast-Acting Antioxidant Liquid
CanPrev Liposomal NAC delivers 60mg of N-Acetyl-Cysteine per teaspoon, carried in a soy-free, bio-friendly phospholipid liposomal system designed for rapid and sustained cellular uptake. A natural strawberry-flavoured liquid - no capsules. Provides antioxidants. Licensed Natural Health Product, NPN 80109358. Licensed Natural Health Product NPN 80109358.
CanPrev NAC Liposomal offre 60 mg de N-acétylcystéine par cuillère à thé, dans un système liposomal de phospholipides sans soya et biocompatible, conçu pour une absorption cellulaire rapide et soutenue. Un liquide naturel aromatisé à la fraise - sans capsules. Fournit des antioxydants. Produit de santé naturel homologué, NPN 80109358.
One Focused Antioxidant, One Liposomal Liquid
60mg N-Acetyl-Cysteine per Teaspoon - Vegan, Non-GMO, Gluten-Free, Soy-Free Phospholipids
Liposomal Delivery, Not a Capsule
Bio-friendly phospholipid bilayers, sourced from sunflower rather than soy, are designed to protect NAC from digestive breakdown and support rapid, sustained cellular uptake.
A Building Block for the Body's Own Antioxidant
NAC is a stable form of the amino acid cysteine - the rate-limiting precursor the body uses to synthesize glutathione, its main intracellular antioxidant.
What CanPrev Liposomal NAC Supports
N-Acetyl-Cysteine (NAC) is one of the most widely studied antioxidant-supporting nutrients. Here's what's inside every teaspoon of CanPrev Liposomal NAC.
Antioxidant Support
Provides antioxidants - NAC is a stable form of cysteine, the rate-limiting building block the body uses to make glutathione, its main intracellular antioxidant.
Liposomal Absorption
A soy-free phospholipid liposomal liquid designed for rapid, sustained cellular uptake compared with a standard capsule.
Convenient Liquid Format
A simple one-teaspoon daily liquid dose, naturally strawberry-flavoured, with no capsules to swallow.
Clean, Vegan Formula
Vegan, non-GMO, gluten-free, dairy-free and soy-free, made without artificial colours, flavours or preservatives.
CanPrev Liposomal NAC: Supplement Facts
Medicinal Ingredients (per teaspoon, 5ml)
- NAC (N-Acetyl-Cysteine) per teaspoon60 mg
Non-Medicinal Ingredients: Non-medicinal ingredients: Purified water, natural strawberry flavour, natural raspberry flavour, natural vanilla flavour, xylitol, oleic acid, citric acid, sunflower oil, phosphatidylcholine, glycerin, d-alpha tocopherol, beta-carotene, potassium bicarbonate, sucrose.
Recommended Use or Purpose: NAC Liposomal provides antioxidants.
Recommended Dose (Adults): Take one (1) teaspoon (5ml) per day with food, or as directed by a health care practitioner. Shake before use. Refrigerate after opening.
Cautions and Warnings: As with any natural health product, you should consult a health care practitioner prior to use if you are pregnant or breastfeeding, or if you have kidney stones. Consult a health care practitioner if symptoms persist or worsen. Do not use if the safety seal is broken. Keep out of reach of children. Shake well before use. Refrigerate after opening.
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. Made in the USA for CanPrev Natural Health Products Ltd., Toronto, ON, Canada. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.
Ingrédients médicinaux (par cuillère à thé, 5 ml)
- NAC (N-acétylcystéine) par cuillère à thé60 mg
Ingrédients non médicinaux : Ingrédients non médicinaux : Eau purifiée, arôme de fraise naturel, arôme de framboise naturel, arôme naturel de vanille, xylitol, acide oléique, acide citrique, huile de tournesol, phosphatidylcholine, glycérine, d-alpha tocophérol, bêta-carotène, bicarbonate de potassium, sucrose.
Usage ou fins recommandés : NAC Liposomal fournit des antioxydants.
Posologie recommandée (adultes) : Prendre une (1) cuillère à thé (5 ml) par jour avec de la nourriture, ou selon les directives d'un praticien de soins de santé. Agiter avant usage. Réfrigérer après ouverture.
Mises en garde et avertissements : Comme avec tout produit de santé naturel, vous devriez consulter un praticien de soins de santé avant l'usage si vous êtes enceinte ou allaitez, ou si vous avez des calculs rénaux. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Ne pas utiliser si le sceau de sécurité est brisé. Tenir hors de portée des enfants. Agiter avant utilisation. Réfrigérer après ouverture.
NPN 80109358
Add CanPrev Liposomal NAC to your daily routine
Get CanPrev Liposomal NAC on Amazon.ca - fast, protected delivery.
Get it on Amazon.caWhy CanPrev Liposomal NAC
60mg N-Acetyl-Cysteine in a fast-acting, soy-free liposomal liquid - premium CanPrev quality.
Liposomal, not just liquid
Soy-free sunflower phospholipid bilayers are designed to protect NAC in transit and support rapid, sustained cellular uptake - not just a flavoured liquid version of a capsule.
A building block for glutathione
NAC is a stable form of the amino acid cysteine - the rate-limiting precursor the body uses to make glutathione, one of the most-studied antioxidants in nutrition science.
No capsules, natural strawberry flavour
A pleasant strawberry-flavoured liquid, taken by the teaspoon, with no artificial colours, flavours or preservatives.
Trusted Canadian brand
CanPrev - a licensed Natural Health Product, NPN 80109358.
How to use it
Shake well before use
Shake the bottle well before each use to ensure the liposomal liquid is evenly mixed.
Take 1 teaspoon (5ml) per day
Adults: take one (1) teaspoon per day with food, or as directed by a health care practitioner.
Refrigerate after opening
Store in a cool, dry place before opening; refrigerate the bottle once opened.
Consult a practitioner if pregnant, breastfeeding, or with kidney stones
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, or if you have kidney stones.
What the research says about N-Acetyl-Cysteine (NAC) and liposomal delivery
Educational summaries of published research on N-Acetyl-Cysteine generally, and on liposomal/phospholipid delivery technology broadly - these are not product-specific claims. CanPrev Liposomal NAC's own claim is the authorized use under NPN 80109358: it provides antioxidants.
NAC is one of two glutathione precursors reviewed for metabolic health
A 2026 review of dietary interventions for obesity and metabolic health highlights N-acetylcysteine and glycine as glutathione precursors, noting NAC shows promising benefits for insulin resistance, hepatic steatosis and cellular senescence, largely through antioxidant and anti-inflammatory mechanisms - though the authors note research in this area remains limited and mostly preclinical.
ReviewLow glutathione is linked to a wide range of chronic conditions
A review of glutathione's role in chronic illness describes it as the body's most abundant thiol antioxidant, noting that low glutathione levels are associated with metabolic syndrome, cardiovascular, renal, hepatic and neurodegenerative conditions, and that precursor supplementation such as NAC showed improved outcomes across several of these areas in preliminary human and animal trials.
ReviewCysteine is the rate-limiting building block for the body's main antioxidant
A review of cysteine and selenocysteine in redox biology describes cysteine as the rate-limiting precursor for glutathione synthesis, and notes N-acetylcysteine supplementation has shown protective antioxidant effects in preclinical models of oxidative retinal stress.
ReviewA meta-analysis of 11 trials found NAC reduced chronic bronchitis exacerbations
Pooling 11 published trials (775 patients on NAC vs 789 on placebo), a meta-analysis found oral NAC significantly reduced the frequency of chronic bronchitis exacerbations and improved symptoms compared with placebo, without increasing adverse effects, at regular low-dose use (under 1200mg per day) for at least 3 months.
Meta-analysisA Cochrane review of 38 trials found mucolytics like NAC modestly reduced exacerbations
A Cochrane review of 38 randomized trials (10,377 participants) found oral mucolytics, including N-acetylcysteine, were associated with a small but real reduction in the likelihood of an acute exacerbation and fewer days of disability per month in chronic bronchitis or COPD, with no clear increase in adverse events - though the authors note high heterogeneity and more modest effects in more recent trials.
Cochrane meta-analysisHigher doses of NAC showed stronger effects in patients with airway obstruction
A meta-analysis of 13 studies (4,155 COPD patients) found NAC-treated patients had significantly fewer chronic bronchitis or COPD exacerbations overall, with the protective effect most apparent in patients without airway obstruction at regular dosing, while higher doses (over 600mg per day) were needed to show a benefit in patients with confirmed airway obstruction.
Meta-analysisA 1-year high-dose NAC trial improved small-airway function
In the 1-year, double-blind HIACE trial, 120 patients with stable COPD given NAC 600mg twice daily saw significant improvement in small-airway function measures and a reduction in exacerbation frequency (0.96 vs 1.71 per year) compared with placebo, with no major adverse effects reported.
Human RCTThe benefit of high-dose NAC was concentrated in higher-risk COPD patients
A follow-up analysis of the same trial cohort found high-dose NAC (600mg twice daily) significantly reduced exacerbation frequency and prolonged time to first exacerbation in high-risk COPD patients, but the benefit was not statistically significant in patients classified as low-risk - an example of how patient selection affects study outcomes.
Human RCTA more recent, larger trial found no significant benefit in mild-to-moderate COPD
In a 2024 randomized trial of 968 patients with mild-to-moderate COPD followed for 2 years, high-dose NAC (600mg twice daily) did not significantly reduce the annual rate of exacerbations or improve lung function compared with placebo - an honest counterpoint showing results have varied by COPD severity and trial design.
Human RCT (null result)Separate meta-analyses found NAC improved both exacerbations and quality of life
A 2024 set of meta-analyses covering 20 studies found NAC-treated patients had a significantly lower incidence of exacerbations in both COPD and chronic-bronchitis/pre-COPD populations, and were significantly more likely to report an improvement in respiratory symptoms or quality of life compared with placebo.
Meta-analysisNAC's role is explained by replenishing glutathione faster than the lungs can use it up
A review of the oxidation pathway in COPD explains that glutathione is an intracellular antioxidant the lungs upregulate to counter oxidative stress, but this response becomes inadequate during exacerbations - NAC acts as a precursor for the cysteine substrate needed to synthesize glutathione, in addition to its direct mucolytic and anti-inflammatory actions.
ReviewNAC's antioxidant effect is context-dependent, not simply 'more is better'
A 2026 mini-review of NAC combined with hyperbaric oxygen therapy found the interaction is context-dependent: NAC can enhance therapeutic effects when oxidative stress is pathologically excessive, but may blunt beneficial effects where reactive oxygen species act as normal signaling molecules for adaptive or regenerative pathways - a reminder that antioxidant supplementation is not simply 'more is always better.'
ReviewNAC is a precursor to cysteine and glutathione, central to the liver's detox pathway
A review of liver disease treatments describes N-acetylcysteine as a precursor to L-cysteine and glutathione, noting that due to its antioxidant and anti-inflammatory actions, NAC is the most accepted treatment for drug-induced liver injury (particularly after acetaminophen overdose) and has also been used for chronic liver injuries including hepatosteatosis and fibrosis.
ReviewGlutathione's detox chemistry against a classic liver toxin, explored at the molecular level
A 2026 mouse study found that hepatic 'supersulfide' forms of glutathione help detoxify the reactive toxin generated by acetaminophen overdose, and that NAC-derived supersulfide donors reduced liver injury more effectively than conventional NAC in this animal model - illustrating the depth of ongoing research into how glutathione-pathway compounds protect the liver.
Animal studyA postoperative liver-function case where NAC was used off-label
A published case report describes a patient with postoperative liver dysfunction (with normal acetaminophen levels) whose liver function improved considerably after intravenous NAC was administered, with the authors reviewing NAC's known glutathione-stimulating, detoxifying and free-radical-scavenging actions - a single case, not proof of general efficacy, but illustrative of why clinicians have explored NAC in liver contexts beyond acetaminophen overdose.
Case reportEncapsulating NAC itself in a lipid-based carrier changed its performance in an animal study
A rat study encapsulated N-acetylcysteine in PEGylated nano-niosomes (a lipid-vesicle carrier related to liposomes) and found the encapsulated NAC was more effective than standard NAC at improving liver-enzyme and oxidative-stress markers after an acetaminophen overdose - direct evidence that how NAC is delivered can change its measured effect, in this specific animal model.
Animal studyLipid-based encapsulation out-performed a free antioxidant in a liver-protection study
In rats with induced acute liver toxicity, an antioxidant (astaxanthin) encapsulated in liposomes for better absorption produced a stronger protective effect on liver-injury and inflammation markers than the same antioxidant left unencapsulated - and even outperformed standard NAC used as the study's positive-control comparison in this specific model - illustrating the general principle behind liposomal antioxidant delivery.
Animal studyPhosphatidylcholine liposomes improved oral absorption in a rat model
A liposome-encapsulated formulation made with phosphatidylcholine achieved 68% encapsulation efficiency and produced better absorption pharmacokinetics after oral dosing in rats compared with unencapsulated forms of the same active - general liposome-delivery research on the phospholipid technology rather than any single ingredient, honestly reused from CanPrev's other liposomal-liquid research files per established house precedent.
Animal studyA pilot trial found NAC well tolerated at 3.75g/day over 4 weeks
A randomized pilot trial in adults with progressive multiple sclerosis gave NAC 1250mg three times daily (3.75g/day total) for 4 weeks and found it was well tolerated, with a similar rate of mild adverse events (60%) as the placebo group (80%) - though fatigue improvement did not differ significantly from placebo in this small study.
Human RCTA dose-escalation trial in children found intravenous NAC safe up to the study dose
A phase I dose-escalation trial in children receiving cisplatin chemotherapy tested intravenous NAC (a different route than this product's oral liquid) up to 450mg/kg, finding the maximum tolerated dose was not reached and no severe adverse events occurred, while also reducing the likelihood of cisplatin-related hearing loss.
Human trialNAC was generally well tolerated in an 8-week pediatric trial
A randomized, placebo-controlled pilot trial gave children and adolescents with neurofibromatosis type 1 oral NAC at approximately 70mg/kg/day for 8 weeks and found it was generally well tolerated, though it did not significantly improve the motor or cognitive outcomes measured in this population.
Human RCTNAC improved muscle fatigue resistance in an animal model of impaired blood flow
In a mouse model of peripheral arterial insufficiency, daily NAC injections improved fatigue resistance in the soleus muscle compared with saline-treated controls, though the effect was specific to that muscle and the injection route tested in this study.
Animal studyA systematic review finds NAC's muscle benefits are still mostly preclinical
A 2026 systematic review of NAC and skeletal muscle health across aging and disease models found consistent improvements in muscle force and reduced inflammatory markers across several animal studies, but noted human evidence remains scarce and limited mainly to acute fatigue recovery - concluding that well-designed human trials, particularly in older adults, are still needed.
Systematic reviewIn people with mild COPD, oral NAC raised glutathione but did not improve exercise tolerance
A randomized crossover trial gave patients with mild COPD oral NAC (1800mg/day) for 4 days and found it raised plasma glutathione by about 27% compared with placebo, but this change did not translate into any measurable improvement in exercise tolerance, muscle oxygenation or blood flow during exercise testing - an honest example of a biomarker change that did not produce a functional benefit in this specific trial.
Human RCT (null result)Frequently asked questions
What is CanPrev Liposomal NAC and what does it do?
It's a liposomal liquid supplement providing 60mg of N-Acetyl-Cysteine (NAC) per teaspoon. Its Health Canada-authorized use is that it provides antioxidants.
How do I take it?
Adults: take one (1) teaspoon (5ml) per day with food, or as directed by a health care practitioner. Shake well before use and refrigerate after opening.
What does 'liposomal' mean, and why does it matter?
CanPrev's liposomal technology wraps NAC in bio-friendly phospholipid bilayers - the same basic building blocks as cell membranes - sourced from sunflower rather than soy. This is designed to protect NAC from digestive and enzymatic breakdown in transit and support rapid, sustained cellular uptake, compared with a standard capsule or tablet.
What is NAC and how is it related to glutathione?
N-Acetyl-Cysteine (NAC) is a stable form of the amino acid cysteine. Cysteine is the rate-limiting building block the body uses to synthesize glutathione, its main intracellular antioxidant - which is why NAC is widely studied as a way to support the body's own antioxidant defenses.
Is it vegan and allergen-friendly?
Yes - vegan, non-GMO, gluten-free, dairy-free and soy-free, with no artificial colours, flavours or preservatives. The liposomal phospholipids are sourced from sunflower, not soy.
Who should not use it?
Do not use if you are taking antibiotics or nitroglycerin. Consult a health care practitioner before use if you are pregnant or breastfeeding, or if you have kidney stones. Do not use if the safety seal is broken. Keep out of reach of children.
How long does one bottle last?
Each 225ml bottle provides 45 teaspoon servings - a 45-day supply at the labelled adult dose of 1 teaspoon per day.
Where is it made?
CanPrev Liposomal NAC is made in the USA for CanPrev Natural Health Products Ltd. (Toronto, ON, Canada), and is a licensed Natural Health Product under NPN 80109358.
Where do I buy it?
Use the orange button on this page - it takes you to the CanPrev listing on Amazon.ca for secure checkout and fast delivery.
Add CanPrev Liposomal NAC to your daily routine
Get CanPrev Liposomal NAC on Amazon.ca - fast, protected delivery.
Get it on Amazon.caNatural Health Product NPN 80109358. NAC Liposomal provides antioxidants. The research summaries below concern N-Acetyl-Cysteine (NAC) generally, and liposomal/phospholipid delivery technology broadly, and are educational - they are not claims about this finished product. Do not use if you are taking antibiotics or nitroglycerin. Consult a health care practitioner prior to use if you are pregnant or breastfeeding, or if you have kidney stones. Do not use if the safety seal is broken. Keep out of reach of children. Shake well before use. Refrigerate after opening. Read and follow the label. Results may vary.
Important information
Safety Information
Cautions and Warnings: As with any natural health product, you should consult a health care practitioner prior to use if you are pregnant or breastfeeding, or if you have kidney stones. Consult a health care practitioner if symptoms persist or worsen. Do not use if the safety seal is broken. Keep out of reach of children. Shake well before use. Refrigerate after opening.
Indications
Recommended Use or Purpose: NAC Liposomal provides antioxidants.
Ingredients
Medicinal Ingredients (1 teaspoon, 5ml): NAC (N-Acetyl-Cysteine) 60 mg. Non-medicinal ingredients: Purified water, natural strawberry flavour, natural raspberry flavour, natural vanilla flavour, xylitol, oleic acid, citric acid, sunflower oil, phosphatidylcholine, glycerin, d-alpha tocopherol, beta-carotene, potassium bicarbonate, sucrose. Contraindications: Do not use this product if you are taking antibiotics or nitroglycerin. Vegan, GMO-free, no gluten, dairy, soy, wheat, yeast, sugar, artificial colours, flavours, preservatives or animal products. NMIs are subject to change - always read and follow the label for accurate ingredients, cautions and allergen information.
Directions
Recommended Dose (Adults): Take one (1) teaspoon (5ml) per day with food, or as directed by a health care practitioner. Shake before use. Refrigerate after opening.
Legal Disclaimer
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. Made in the USA for CanPrev Natural Health Products Ltd., Toronto, ON, Canada. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.